News & Views

Read the latest from Baszucki Group and its partners.

Fox News: Popular weight-loss diet shows surprising impact on serious mental health condition

June 4, 2026—Most participants scored in the recovered or normal range on eating disorder questionnaires after 14 weeks.

Read More

New Scientist: Keto diet shows real promise for anorexia recovery

June 3, 2026—Restricting carbohydrates may sound like an unlikely approach to treating anorexia, but following a ketogenic diet was linked to recovery in nearly 75 per cent of people with the eating disorder in a small trial

Read More

New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa

A pilot study published today in Communications Medicine demonstrates the potential of a new approach to treating anorexia nervosa — a disorder for which effective treatments have been significantly limited.

Read More

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy’s ability to improve patients’ mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness.

Read More